HOME >> BIOLOGY >> NEWS
Medication reconciliation, pharmacist involvement vital to reducing medication errors, study finds

CHICAGO Obtaining complete and accurate medication histories of patients and instituting a medication reconciliation program are vital to reducing medication errors, a new study conducted at Northwestern Memorial Hospital has shown. The study demonstrated that when hospital pharmacists perform medication reconciliation, taking steps to ensure patients receive the correct medication and accurate dosage, the number of medication errors dropped and with them the potential for patient injury.

"A medication error, once in a patient's medical record, can carry-over from admission through discharge unless medication reconciliation is performed," says Kristine Gleason, who is on the hospital's Patient Safety Team and is the lead author of the study, Reconciliation of Discrepancies in Medication Histories and Admission Orders of Newly Hospitalized Patients. "Doctors, nurses, pharmacists and patients often just assume medical histories are accurate, and that's not always the case."

The study findings, published this week in the American Journal of Health-System Pharmacy, are particularly significant in light of the recent announcement by the Joint Commission on Accreditation of Healthcare Organizations that medication reconciliation for all hospital patients is one of its 2005 National Patient Safety Goals. That means medication reconciliation programs are a requirement for accreditation.

Northwestern Memorial is working toward that goal, implementing a computerized prescriber order entry (CPOE) system as part of its patient safety initiative. A previous study at Northwestern Memorial found that a combination of pharmacist involvement and a CPOE system with significant clinical decision support will likely provide the best approach to improve medication safety among patients.

Data collected by Northwestern Memorial researchers for the new study showed that in the absence of a pharmacist intervention, 22 percent of medication discrepan
'"/>

Contact: Andrew Buchanan
anbuchan@nmh.org
312-926-6503
Northwestern Memorial Hospital
16-Aug-2004


Page: 1 2 3

Related biology news :

1. Possible Dangers Of Taking Over-The-Counter Medications For Hepatitis C Patients
2. Common Anti-Viral Medication Prevents Severe Eye Herpes
3. New Medication Means New Choices For Families Dealing With Alzheimers Disease
4. Study Reviews Medication Use In Elderly Cardiac Patients After Discharge
5. Call for greater involvement of developing world scientists in fight against AIDS
6. Yale researchers shed light on B cells involvement in autoimmune diseases like lupus
7. Education, monitoring vital for sport-fish eaters
8. Life goes on without vital DNA
9. Rb2 expression could play vital role in ovarian cancer Temple University researchers find
10. Vascular access vital to pump up tissue engineering
11. Study links amyloid plaques in Alzheimers brains to genes vital to normal memory

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... , June 23, 2016 A person commits ... the crime scene to track the criminal down. ... U.S. Food and Drug Administration (FDA) uses DNA evidence to ... Sound far-fetched? It,s not. The FDA has ... to support investigations of foodborne illnesses. Put as simply as ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. , ... tests introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial ...
Breaking Biology Technology:
Cached News: